Article Information
History
- December 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Wilfredo F. Garcia-Beltran1,2,3,*,
- Kerri J. St. Denis1,3,
- Angelique Hoelzemer4,5,
- Evan C. Lam3,
- Adam D. Nitido3,
- Maegan L. Sheehan3,
- Cristhian Berrios2,
- Onosereme Ofoman2,
- Christina C. Chang6,
- Blake M. Hauser3,
- Jared Feldman3,
- David J. Gregory7,8,
- Mark C. Poznansky7,9,
- Aaron G. Schmidt3,
- A. John Iafrate2,
- Vivek Naranbhai6,9,10 and
- Alejandro B. Balazs3,*
- 2Department of Pathology, Massachusetts General Hospital, Boston, MA, 02114, USA
- 3Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA
- 4First Department of Internal Medicine, Division of Infectious Diseases, University Medical Centre Eppendorf, Hamburg, Germany
- 5German Center for Infection Research (DZIF), Site Hamburg-Lübeck-Borstel-Riems, Germany
- 6Center for the AIDS Programme of Research in South Africa, Durban, 4001, South Africa
- 7Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, 02129, USA
- 8Pediatric Infectious Disease, Massachusetts General Hospital for Children, Boston, MA 02114, USA
- 9Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA
- 10Dana-Farber Cancer Institute, Boston, MA, 02215, USA
- ↵*Corresponding authors: Alejandro B. Balazs, Ragon Institute of MGH, MIT, and Harvard, 400 Technology Square, Cambridge, MA 02139, USA, abalazs{at}mgh.harvard.edu; Wilfredo F. Garcia-Beltran, Ragon Institute of MGH, MIT, and Harvard, 400 Technology Square, Cambridge, MA 02139, USA, wgarciabeltran{at}mgh.harvard.edu
↵1 These authors contributed equally
Posted December 14, 2021.
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
